22 Jan 2015
An ageing population, expanding middle class and changing lifestyles have turned non-prescription (OTC) healthcare into one of Brazil’s fastest-growing consumer sectors.
Generic drugs are gaining ground in the prescription sector of the market, with the trend benefiting bigger companies.
Infrastructure companies are starting to make use of new funding mechanisms, but we do not see large foreign inflows in the near future.
The formation of the EBP is one of several moves that should pave the way for faster infrastructure development.
Brazil’s high prices aren’t just a result of spiralling costs – they are a way for brands to distinguish themselves, says Rodrigo Moita of Insper business school.
Local commentators debate the government's initiative to attract foreign workers.
Forecasters are revising their expectations for 2013, leading commentators to question the wisdom of the government's aggressive approach to electricity concession renewals.